BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
304 hedge funds and large institutions have $7.15B invested in Blueprint Medicines in 2024 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 114 increasing their positions, 100 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
304
Holders Change
+22
Holders Change %
+7.8%
% of All Funds
4.42%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.12%
New
50
Increased
114
Reduced
100
Closed
25
Calls
$295M
Puts
$140M
Net Calls
+$155M
Net Calls Change
+$121M
Top Buyers
| 1 |
Millennium Management
New York
|
+$58.2M |
| 2 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$54.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.6M |
| 4 |
Holocene Advisors
New York
|
+$24.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.9M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$101M |
| 2 |
Pictet Asset Management
Carouge,
Switzerland
|
-$79.5M |
| 3 |
Morgan Stanley
New York
|
-$68.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$40.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$36.2M |
